FR2829136B1 - Derives lipidiques d'aminoglycosides - Google Patents

Derives lipidiques d'aminoglycosides

Info

Publication number
FR2829136B1
FR2829136B1 FR0111199A FR0111199A FR2829136B1 FR 2829136 B1 FR2829136 B1 FR 2829136B1 FR 0111199 A FR0111199 A FR 0111199A FR 0111199 A FR0111199 A FR 0111199A FR 2829136 B1 FR2829136 B1 FR 2829136B1
Authority
FR
France
Prior art keywords
aminoglycosides
lipid derivatives
lipid
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0111199A
Other languages
English (en)
Other versions
FR2829136A1 (fr
Inventor
Jean Marie Lehn
Pierre Lehn
Jean Pierre Vigneron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0111199A priority Critical patent/FR2829136B1/fr
Priority to US10/228,959 priority patent/US7772003B2/en
Priority to JP2003523262A priority patent/JP4629333B2/ja
Priority to PCT/FR2002/002959 priority patent/WO2003018603A1/fr
Priority to DE60232258T priority patent/DE60232258D1/de
Priority to AU2002334051A priority patent/AU2002334051B2/en
Priority to CA2458626A priority patent/CA2458626C/fr
Priority to EP02796324A priority patent/EP1430074B1/fr
Priority to AT02796324T priority patent/ATE430758T1/de
Publication of FR2829136A1 publication Critical patent/FR2829136A1/fr
Application granted granted Critical
Publication of FR2829136B1 publication Critical patent/FR2829136B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0111199A 2001-08-29 2001-08-29 Derives lipidiques d'aminoglycosides Expired - Lifetime FR2829136B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0111199A FR2829136B1 (fr) 2001-08-29 2001-08-29 Derives lipidiques d'aminoglycosides
US10/228,959 US7772003B2 (en) 2001-08-29 2002-08-28 Lipid derivatives of aminoglycosides
PCT/FR2002/002959 WO2003018603A1 (fr) 2001-08-29 2002-08-29 Derives lipidiques d'aminoglycosides_pour la transfection
DE60232258T DE60232258D1 (de) 2001-08-29 2002-08-29 Lipid-aminoglykosid konjugate zur transfektion
JP2003523262A JP4629333B2 (ja) 2001-08-29 2002-08-29 アミノグリコシドの脂質誘導体
AU2002334051A AU2002334051B2 (en) 2001-08-29 2002-08-29 Aminoglycoside lipid derivatives for transfection
CA2458626A CA2458626C (fr) 2001-08-29 2002-08-29 Derives lipidiques d'aminoglycosides pour la transfection
EP02796324A EP1430074B1 (fr) 2001-08-29 2002-08-29 Derives lipidiques d'aminoglycosides-pour la transfection
AT02796324T ATE430758T1 (de) 2001-08-29 2002-08-29 Lipid-aminoglykosid konjugate zur transfektion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0111199A FR2829136B1 (fr) 2001-08-29 2001-08-29 Derives lipidiques d'aminoglycosides

Publications (2)

Publication Number Publication Date
FR2829136A1 FR2829136A1 (fr) 2003-03-07
FR2829136B1 true FR2829136B1 (fr) 2006-11-17

Family

ID=8866791

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0111199A Expired - Lifetime FR2829136B1 (fr) 2001-08-29 2001-08-29 Derives lipidiques d'aminoglycosides

Country Status (2)

Country Link
US (1) US7772003B2 (fr)
FR (1) FR2829136B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006125165A2 (fr) * 2005-05-19 2006-11-23 Clemson University Methodes et compositions pour faciliter l'entree de composes dans des cellules
WO2008040792A2 (fr) 2006-10-04 2008-04-10 Centre National De La Recherche Scientifique (Cnrs) COMPOSITIONS INCLUANT UN siARN ET DES DÉRIVÉS LIPIDIQUES D'AMINOGLYCOSIDE À NOYAU 2-DÉSOXYSTREPTAMINE 4,5-DISUBSTITUÉE ET LEURS UTILISATIONS
CA2729852A1 (fr) * 2008-07-09 2010-01-14 University Of Manitoba Aminoglycosides ameliores au plan de l'hydrophobicite
EP2542265A2 (fr) * 2010-03-05 2013-01-09 The University of Manitoba Conjugués aminoglycoside-lipide guanidinylés

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293128A (en) * 1961-11-24 1966-12-20 Lilly Co Eli Anthelmintic hygromycin b derivatives and process of using same
BE758942A (fr) * 1969-11-15 1971-04-16 Abbou Richard Medicament pour le traitement d'affections infectieuses et/ou inflammatoires
US4400375A (en) * 1981-11-23 1983-08-23 Eli Lilly And Company Tobramycin-double stranded RNA complex suitable for inducing interferon
DE3486053T3 (de) 1983-10-20 2004-01-08 The Research Foundation Of State University Of New York Regulierung von Gen-Expression durch Translationshemmung unter Verwendung von m-RNS hinderndem Komplementär-RNS.
FR2573436B1 (fr) 1984-11-20 1989-02-17 Pasteur Institut Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
US6696420B1 (en) 1984-11-20 2004-02-24 Institut Pasteur Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein
US5744133A (en) 1986-08-13 1998-04-28 Transgene S.A. Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor
FR2602790B1 (fr) 1986-08-13 1990-06-01 Transgene Sa Expression d'un antigene specifique de tumeur par un virus vecteur recombinant et utilisation de celui-ci pour le traitement preventif ou curatif de la tumeur correspondante
ATE115999T1 (de) 1987-12-15 1995-01-15 Gene Shears Pty Ltd Ribozyme.
US5543389A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
FR2681786A1 (fr) 1991-09-27 1993-04-02 Centre Nat Rech Scient Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires.
US6743623B2 (en) 1991-09-27 2004-06-01 Centre National De La Recherche Scientifique Viral recombinant vectors for expression in muscle cells
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
FR2704234B1 (fr) 1993-04-22 1995-07-21 Centre Nat Rech Scient Virus recombinants, preparation et utilisation en therapie genique.
FR2704556B1 (fr) 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
WO1996024334A1 (fr) * 1995-02-10 1996-08-15 Nexstar Pharmaceuticals, Inc. Produits de synthese lipidique destines a la diffusion cytoplasmique d'agents
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
FR2739292B1 (fr) 1995-09-28 1997-10-31 Rhone Poulenc Rorer Sa Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
FR2741066B1 (fr) 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
DK0888379T3 (da) 1996-03-01 2001-01-29 Centre Nat Rech Scient Forbindelser tilhørende amidinium-familien, farmaceutiske præparater indeholdende disse forbindelser og anvendelsen deraf
JP2001510457A (ja) * 1996-11-12 2001-07-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア インビボ送達に有効な、脂質―核酸複合体の安定な製剤の調製
FR2764304B1 (fr) * 1997-06-06 1999-07-16 Rhone Poulenc Rorer Sa Nouvelle classe d'agents transfectants cationiques des acides nucleiques
WO1999012945A2 (fr) * 1997-09-08 1999-03-18 Valentis,Inc. Derives de glycosylamine hydrophobes, compositions a base de ces derives et procedes d'utilisation
IL127773A0 (en) * 1998-12-28 1999-10-28 Yeda Res & Dev Saccharide conjugates and pharmaceutical compositions comprising them
WO2000040692A2 (fr) * 1999-01-05 2000-07-13 Valentis, Inc. Methodes d'administration d'acides nucleiques et compositions a cet effet
GB9930533D0 (en) * 1999-12-23 2000-02-16 Mitsubishi Tokyo Pharm Inc Nucleic acid delivery

Also Published As

Publication number Publication date
US7772003B2 (en) 2010-08-10
FR2829136A1 (fr) 2003-03-07
US20030054556A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
FR20C1039I2 (fr) Derives de l'uk-2a
FR18C1024I2 (fr) Derives d'heterocyclocarboxamide
AR028567A1 (es) Nuevos derivados de fenil-propargileter
MA26816A1 (fr) Derives d'amino-triazolopyridine
MA26932A1 (fr) Derives d'imidazole.
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20040198L (no) Dolastatin 10 derivater
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
CY2012006I1 (el) Φωσφονικα παραγωγα γλυκοπεπτιδιων
ATE319451T1 (de) Tetrahydrochinolin-derivate
MA27083A1 (fr) Derives de nicotine ou d'isonicotine benzothiazole
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
CY2009001I1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
AR027985A1 (es) Derivados de diazepam o sus sales
EP1275643A4 (fr) Derives de la vitamine d
MA26941A1 (fr) Nouveaux derives d'aminocyclohexane
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
FR2878850B1 (fr) Derives de l'inositol-1-phosphate
MA27240A1 (fr) Derives d'imidazoquinoleine
FR2829136B1 (fr) Derives lipidiques d'aminoglycosides
FR2824557B1 (fr) Derives lipidiques de polythiouree
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200200389A (et) Imidasooli uued derivaadid

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20